UT
Ursina R. Teitelbaum
Highly rated in
27
conditions
Highly rated in
27
conditions
Check Dr. Ursina R. Teitelbaum's experience treating your condition:
About Dr. Ursina R. Teitelbaum

Ursina Teitelbaum is an Oncologist and a Palliative Medicine expert in Philadelphia, Pennsylvania. Teitelbaum has been practicing medicine for over 24 years and is highly rated in 27 conditions, according to our data. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Liver Embolization, and Bone Marrow Transplant. She is licensed to treat patients in Pennsylvania. Teitelbaum is currently accepting new patients.

Her clinical research consists of co-authoring 33 peer reviewed articles and participating in 3 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Ursina R. Teitelbaum it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Ursina R. Teitelbaum accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
3400 Civic Center Blvd, Philadelphia, PA 19104
Other Locations
Philadelphia, PA 19104
Background & Education
Graduate Institution
University Of Maryland School Of Medicine, 1999
Specialties
Oncology
Palliative Medicine
Hematology Oncology
Licenses
Hospice and Palliative Medicine in PA
Hospital Affiliations
Chester County Hospital
Princeton Medical Center
Hospital Of The University Of Pennsylvania
Penn Presbyterian Medical Center
Pennsylvania Hospital
Languages Spoken
English
French
German
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers
Phase II Trial of Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma
A Phase I/II Pharmacodynamic Study of Hydroxychloroquine in Combination With FOLFOX Plus Bevacizumab to Inhibit Autophagy in Colorectal Cancer
View 2 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors